SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xin Song, Eero Pukkala, Tadeusz Dyba, Jaakko Tuomilehto, Vladislav Moltchanov, Satu Männistö, Pekka Jousilahti, Qing Qiao, Body mass index and cancer incidence: the FINRISK study, European Journal of Epidemiology, 2014, 29, 7, 477

    CrossRef

  2. 2
    Stacey J. Winham, Sebastian M. Armasu, Mine S. Cicek, Melissa C. Larson, Julie M. Cunningham, Kimberly R. Kalli, Brooke L. Fridley, Ellen L. Goode, Genome-Wide Investigation of Regional Blood-Based DNA Methylation Adjusted for Complete Blood Counts Implicates BNC2 in Ovarian Cancer, Genetic Epidemiology, 2014, 38, 5
  3. 3
    Liza Makowski, Chunxiao Zhou, Yan Zhong, Pei Fen Kuan, Cheng Fan, Brante P. Sampey, Megan Difurio, Victoria L. Bae-Jump, Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer, Gynecologic Oncology, 2014, 133, 1, 90

    CrossRef

  4. 4
    Michael J. Worley, Stephanie H. Guseh, J. Alejandro Rauh-Hain, Katharine M. Esselen, Michael G. Muto, Colleen M. Feltmate, Ross S. Berkowitz, Marcela G. del Carmen, John O. Schorge, Neil S. Horowitz, What is the optimal treatment for obese patients with advanced ovarian carcinoma?, American Journal of Obstetrics and Gynecology, 2014,

    CrossRef

  5. 5
    Jung-Yun Lee, InPyo Jeon, Jae Weon Kim, Yong-Sang Song, Jae-Moon Yoon, Sang Min Park, Diabetes Mellitus and Ovarian Cancer Risk, International Journal of Gynecological Cancer, 2013, 23, 3, 402

    CrossRef

  6. 6
    Peter Kovacs, Fertility medications and the risk of cancer, Expert Review of Endocrinology & Metabolism, 2013, 8, 2, 159

    CrossRef

  7. 7
    Shi-Wen Jiang, Haibin Chen, Sean Dowdy, Alex Fu, John Attewell, Eleftheria Kalogera, Ronny Drapkin, Karl Podratz, Russell Broaddus, Jinping Li, HE4 Transcription- and Splice Variants-Specific Expression in Endometrial Cancer and Correlation with Patient Survival, International Journal of Molecular Sciences, 2013, 14, 11, 22655

    CrossRef

  8. 8
    C Bodelon, N Wentzensen, S J Schonfeld, K Visvanathan, P Hartge, Y Park, R M Pfeiffer, Hormonal risk factors and invasive epithelial ovarian cancer risk by parity, British Journal of Cancer, 2013, 109, 3, 769

    CrossRef

  9. 9
    Anna Ptak, Elzbieta Kolaczkowska, Ewa L. Gregoraszczuk, Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells, Endocrine, 2013, 43, 2, 394

    CrossRef

  10. 10
    Xiaofei Xu, Zhaogang Dong, Yingwei Li, Yongmei Yang, Zeng Yuan, Xun Qu, Beihua Kong, The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation, The International Journal of Biochemistry & Cell Biology, 2013, 45, 3, 536

    CrossRef

  11. You have free access to this content11
    Lawrence H. Kushi, Colleen Doyle, Marji McCullough, Cheryl L. Rock, Wendy Demark-Wahnefried, Elisa V. Bandera, Susan Gapstur, Alpa V. Patel, Kimberly Andrews, Ted Gansler, American Cancer Society guidelines on nutrition and physical activity for cancer prevention, CA: A Cancer Journal for Clinicians, 2012, 62, 1
  12. 12
    Anna Ptak, Ewa L. Gregoraszczuk, Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK/Stat, MAPK/ERK and PI3K/Akt signalling pathways in human ovarian cancer cell, Toxicology Letters, 2012, 210, 3, 332

    CrossRef

  13. 13
    J.-L. Brun, B. Boubli, A.J. Sasco, Epidemiología de los tumores del ovario, EMC - Ginecología-Obstetricia, 2012, 48, 3, 1

    CrossRef

  14. 14
    J.-L. Brun, B. Boubli, A.J. Sasco, Épidémiologie des tumeurs de l’ovaire, EMC - Gynécologie, 2012, 7, 2, 1

    CrossRef

  15. 15
    Jennifer C. Carter, Frank C. Church, Mature breast adipocytes promote breast cancer cell motility, Experimental and Molecular Pathology, 2012, 92, 3, 312

    CrossRef

  16. 16
    JESSICA HUNN, GUSTAVO C. RODRIGUEZ, Ovarian Cancer, Clinical Obstetrics and Gynecology, 2012, 55, 1, 3

    CrossRef

  17. 17
    Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies, The Lancet Oncology, 2012, 13, 9, 946

    CrossRef

  18. 18
    Daniel W. Cramer, The Epidemiology of Endometrial and Ovarian Cancer, Hematology/Oncology Clinics of North America, 2012, 26, 1, 1

    CrossRef

  19. 19
    Melanie Bevier, Jan Sundquist, Kari Hemminki, Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer?, European Journal of Cancer, 2011, 47, 4, 586

    CrossRef

  20. 20
    J.-H. Choi, K.-T. Lee, P. C. K. Leung, Estrogen receptor alpha pathway is involved in leptin-induced ovarian cancer cell growth, Carcinogenesis, 2011, 32, 4, 589

    CrossRef

  21. 21
    M. Ponnath, O. Ortmann, Orale Kontrazeption und das Risiko gynäkologischer Tumoren, Der Gynäkologe, 2011, 44, 1, 37

    CrossRef

  22. 22
    Yang Zhou, Melinda L. Irwin, Harvey A. Risch, Pre- and post-diagnosis body mass index, weight change, and ovarian cancer mortality, Gynecologic Oncology, 2011, 120, 2, 209

    CrossRef

  23. 23
    Marc A. Lindberg, Yulia Dementieva, Jennifer Cavender, Why Has the BMI Gone Up So Drastically in the Last 35 Years?, Journal of Addiction Medicine, 2011, 5, 4, 272

    CrossRef

  24. 24
    Petra H. Lahmann, Anne E. Cust, Christine M. Friedenreich, Mandy Schulz, Annekatrin Lukanova, Rudolf Kaaks, Eva Lundin, Anne Tjønneland, Jytte Halkjær, Marianne Tang Severinsen, Kim Overvad, Agnès Fournier, Nathalie Chabbert-Buffet, Françoise Clavel-Chapelon, Laure Dossus, Tobias Pischon, Heiner Boeing, Antonia Trichopoulou, Pagona Lagiou, Androniki Naska, Domenico Palli, Sara Grioni, Amalia Mattiello, Rosario Tumino, Carlotta Sacerdote, María-Luisa Redondo, Paula Jakszyn, María-José Sánchez, María-José Tormo, Eva Ardanaz, Larraitz Arriola, Jonas Manjer, Karin Jirström, H. Bas Bueno-de-Mesquita, Anne M. May, Petra H.M. Peeters, N. Charlotte Onland-Moret, Sheila Bingham, Kay-Tee Khaw, Naomi E. Allen, Elizabeth Spencer, Sabina Rinaldi, Nadia Slimani, Véronique Chajes, Dominique Michaud, Teresa Norat, Elio Riboli, Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition, International Journal of Cancer, 2010, 126, 10
  25. 25
    Alison J. Canchola, Ellen T. Chang, Leslie Bernstein, Joan A. Largent, Peggy Reynolds, Dennis Deapen, Katherine D. Henderson, Giske Ursin, Pamela L. Horn-Ross, Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort, Cancer Causes & Control, 2010, 21, 12, 2241

    CrossRef

  26. 26
    J. Tate Thigpen, David Alberts, Michael Birrer, Larry Copeland, Robert L. Coleman, Maurie Markman, Robert C. Bast, Eric L. Eisenhauer, Gini Fleming, Paula M. Fracasso, David M. Gershenson, Thomas Herzog, Bradley J. Monk, Robert F. Ozols, Gordon Rustin, Mark F. Brady, Marissa Shrader, Aarati Ranganathan, Current Challenges and Future Directions in the Management of Ovarian Cancer: Proceedings of the First Global Workshop on Ovarian Cancer, Clinical Ovarian Cancer, 2010, 3, 2, 81

    CrossRef

  27. 27
    Kristine Ansenberger, Cassandra Richards, Yan Zhuge, Animesh Barua, Janice M. Bahr, Judith L. Luborsky, Dale Buchanan Hales, Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 year, Gynecologic Oncology, 2010, 117, 2, 341

    CrossRef

  28. 28
    Andrew G. Renehan, Isabelle Soerjomataram, Michael F. Leitzmann, Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe, European Journal of Cancer, 2010, 46, 14, 2581

    CrossRef

  29. 29
    Fiona Chionh, Laura Baglietto, Kavitha Krishnan, Dallas R. English, Robert J. MacInnis, Dorota M. Gertig, John L. Hopper, Graham G. Giles, Physical activity, body size and composition, and risk of ovarian cancer, Cancer Causes & Control, 2010, 21, 12, 2183

    CrossRef

  30. 30
    Joanna Schwartz, Beth Toste, Don S. Dizon, Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2, Gynecologic Oncology, 2009, 114, 1, 53

    CrossRef

  31. 31
    Ann K. Folkins, Aasia Saleemuddin, Leslie A. Garrett, Judy E. Garber, Michael G. Muto, Shelley S. Tworoger, Christopher P. Crum, Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer, Gynecologic Oncology, 2009, 115, 1, 108

    CrossRef

  32. 32
    Jinping Li, Sean Dowdy, Tracy Tipton, Karl Podratz, Wei-Guo Lu, Xing Xie, Shi-Wen Jiang, HE4 as a biomarker for ovarian  and endometrial cancer management, Expert Review of Molecular Diagnostics, 2009, 9, 6, 555

    CrossRef

  33. 33
    O. W. Brawley, Is Race Really a Negative Prognostic Factor for Cancer?, JNCI Journal of the National Cancer Institute, 2009, 101, 14, 970

    CrossRef

  34. 34
    P. G. Moorman, R. T. Palmieri, L. Akushevich, A. Berchuck, J. M. Schildkraut, Ovarian Cancer Risk Factors in African-American and White Women, American Journal of Epidemiology, 2009, 170, 5, 598

    CrossRef

  35. 35
    Ping Yang, Yong Zhou, Bo Chen, Hong-Wei Wan, Gui-Qing Jia, Hai-Long Bai, Xiao-Ting Wu, Overweight, obesity and gastric cancer risk: Results from a meta-analysis of cohort studies, European Journal of Cancer, 2009, 45, 16, 2867

    CrossRef